Aspireon Wealth Advisors Rani Therapeutics Holdings, Inc. Transaction History
Aspireon Wealth Advisors
- $183 Million
- Q1 2023
A detailed history of Aspireon Wealth Advisors transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Aspireon Wealth Advisors holds 48,129 shares of RANI stock, worth $25,989. This represents 0.14% of its overall portfolio holdings.
Number of Shares
48,129
Previous 48,129
-0.0%
Holding current value
$25,989
Previous $284,000
12.68%
% of portfolio
0.14%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding RANI
# of Institutions
44Shares Held
3.47MCall Options Held
44.3KPut Options Held
111K-
Vanguard Group Inc Valley Forge, PA800KShares$431,8260.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$266,5350.6% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$242,1850.05% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$163,4810.01% of portfolio
-
Geode Capital Management, LLC Boston, MA196KShares$105,9570.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $13.2M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...